FAP and pachyonychia congenita: A gradient of increasing FAP protein expression in prostate tissue microarrays (TMA) from 94 patients at different stages of PC (primary PC, patients undergoing neoadjuvant androgen deprivation therapy, CRPC, and NEPC) was recently reported, indicating a significant rise upon disease progression at the CRPC and NEPC states [19].